Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

8H9C

Crystal structure of chemically modified E. coli ThrS catalytic domain 4

Summary for 8H9C
Entry DOI10.2210/pdb8h9c/pdb
DescriptorThreonine--tRNA ligase, N-(2,3-dihydroxybenzoyl)-4-(4-nitrophenyl)-L-threonine, ZINC ION, ... (4 entities in total)
Functional Keywordsthreonine--trna ligase, ligase
Biological sourceEscherichia coli
Total number of polymer chains1
Total formula weight48363.26
Authors
Qiao, H.,Xia, M.,Wang, J.,Fang, P. (deposition date: 2022-10-25, release date: 2023-02-08, Last modification date: 2023-10-25)
Primary citationQiao, H.,Xia, M.,Cheng, Y.,Zhou, J.,Zheng, L.,Li, W.,Wang, J.,Fang, P.
Tyrosine-targeted covalent inhibition of a tRNA synthetase aided by zinc ion.
Commun Biol, 6:107-107, 2023
Cited by
PubMed Abstract: Aminoacyl-tRNA synthetases (AARSs), a family of essential protein synthesis enzymes, are attractive targets for drug development. Although several different types of AARS inhibitors have been identified, AARS covalent inhibitors have not been reported. Here we present five unusual crystal structures showing that threonyl-tRNA synthetase (ThrRS) is covalently inhibited by a natural product, obafluorin (OB). The residue forming a covalent bond with OB is a tyrosine in ThrRS active center, which is not commonly modified by covalent inhibitors. The two hydroxyl groups on the o-diphenol moiety of OB form two coordination bonds with the conserved zinc ion in the active center of ThrRS. Therefore, the β-lactone structure of OB can undergo ester exchange reaction with the phenolic group of the adjacent tyrosine to form a covalent bond between the compound and the enzyme, and allow its nitrobenzene structure to occupy the binding site of tRNA. In addition, when this tyrosine was replaced by a lysine or even a weakly nucleophilic arginine, similar bonds could also be formed. Our report of the mechanism of a class of AARS covalent inhibitor targeting multiple amino acid residues could facilitate approaches to drug discovery for cancer and infectious diseases.
PubMed: 36707692
DOI: 10.1038/s42003-023-04517-7
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.15 Å)
Structure validation

226707

數據於2024-10-30公開中

PDB statisticsPDBj update infoContact PDBjnumon